Sino Medical Sciences Technology In
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons, intracranial rapid exchange balloons, and intracranial drug-eluting stents. The company was founded in 2007 and is headquartered in Tianjin, China.
Sino Medical Sciences Technology In (688108) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.034x
Based on the latest financial reports, Sino Medical Sciences Technology In (688108) has a cash flow conversion efficiency ratio of 0.034x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥31.52 Million) by net assets (CN¥931.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sino Medical Sciences Technology In - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Sino Medical Sciences Technology In's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sino Medical Sciences Technology In Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sino Medical Sciences Technology In ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hunan Valin Wire & Cable Co Ltd
SHE:001208
|
-0.004x |
|
Huadian Energy
SHG:600726
|
0.010x |
|
SKY Perfect JSAT Holdings Inc.
OTCGREY:SKPJF
|
0.065x |
|
Nokian Renkaat Oyj
PINK:NKRKF
|
0.015x |
|
Shenzhen Yan Tian Port Holdings Co Ltd
SHE:000088
|
0.008x |
|
S&S TECH Corporation
KQ:101490
|
0.045x |
|
URBAN LOGIST.REIT LS -01
F:CW0
|
N/A |
|
Partners Value Investments LP
V:PVF-UN
|
0.001x |
Annual Cash Flow Conversion Efficiency for Sino Medical Sciences Technology In (2016–2024)
The table below shows the annual cash flow conversion efficiency of Sino Medical Sciences Technology In from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥898.34 Million | CN¥131.24 Million | 0.146x | +121.46% |
| 2023-12-31 | CN¥861.65 Million | CN¥56.84 Million | 0.066x | +152.59% |
| 2022-12-31 | CN¥887.48 Million | CN¥-111.31 Million | -0.125x | -97.14% |
| 2021-12-31 | CN¥945.16 Million | CN¥-60.13 Million | -0.064x | -197.25% |
| 2020-12-31 | CN¥1.08 Billion | CN¥70.51 Million | 0.065x | -47.78% |
| 2019-12-31 | CN¥1.10 Billion | CN¥137.61 Million | 0.125x | -9.96% |
| 2018-12-31 | CN¥701.28 Million | CN¥97.56 Million | 0.139x | +20.02% |
| 2017-12-31 | CN¥606.70 Million | CN¥70.32 Million | 0.116x | -44.37% |
| 2016-12-31 | CN¥202.75 Million | CN¥42.24 Million | 0.208x | -- |